Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair loss

Phase 1

Recruiting

• Conditions: Hair loss.; Nonscarring hair loss, unspecified; L65.9

• Registration Number: IRCT20200127046282N13
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 45

Inclusion Criteria

Patients who do not want to take minoxidil.
Patients who are allergic to minoxidil.

Exclusion Criteria

The patient has used an effective drug in hair loss during the last 6 months.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The amount of hair loss. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Trichoscan.

Secondary Outcome Measures

Name	Time	Method
Side effects. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.;Effectiveness. Timepoint: Before starting treatment, end of the first, second, third month and one month after the end of the treatment period (end of the fourth month). Method of measurement: Questionnaire and visit.